IntegriChain’s Growth Drives Executive Promotions and Blue Fin Group Acquisition

IntegriChain is Life Sciences’ data and application mainstay for patient access and therapy commercialization. More than 250 manufacturers rely on IntegriChain’s ICyte Platform to orchestrate commercial and government payer contracting, patient services, and distribution channels.

ICyte is the first and only platform that unites the financial, operational, and commercial data sets required to support therapy access in the era of specialty and precision medicine.

IntegriChain acquired Blue Fin Group, a full-service professional management consulting firm delivering research, strategy, and implementation services to help manufacturers optimize access.

More than 300 Life Sciences manufacturers – spanning cell and gene therapies, orphan/rare, specialty, primary care, vaccines, biosimilars, and generics – have relied on Blue Fin Group to optimize patient outcomes by orchestrating marketing, market access, field sales, pharmacy and distribution, and patient services as a seamless commercial strategy.

Blue Fin Group’s team of nearly 45 consultants and professionals with expertise in market access, drug commercialization, channel strategy, patient funnel pull through, and GTN optimization will operate as an independent division of IntegriChain.

The entire leadership and all employees of Blue Fin Group will remain with the company under the IntegriChain umbrella, creating a global workforce that spans nearly 600 professionals, including more than 65 consultants in total.

This acquisition is IntegriChain’s fifth expansion since entering its strategic partnership in 2016 with Accel-KKR, a leading technology-focused private equity firm.

IntegriChain recently announced key promotions on its executive leadership team following its recent rapid growth. Joshua Halpern, previously Executive Vice President of Product and Strategy, is now President and Chief Operating Officer (COO). 

Bradley Burget, previously Senior Vice President of Operations, has been appointed Chief Technology Officer (CTO). Vickie Koshushchenko, previously Senior Vice President of People and Culture, is now Chief People Officer.

In addition, following IntegriChain’s acquisition of Blue Fin Group, William Roth, the management consulting firm’s founder, will be General Manager and Managing Partner of Blue Fin Group, an IntegriChain Company.

Takeaway: IntegriChain acquisition of Blue Fin Group expands its commercialization capabilities and strengthens the company’s market access expertise